subscribeSubscribe
FDA Confirms Para IV Patent Litigation for Rimegepant Sulfate (Nurtec ODT) Tablets

FDA Confirms Para IV Patent Litigation for Rimegepant Sulfate (Nurtec ODT) Tablets

FDA
26 Apr 2024
Share Share
Lady Gaga returns in a new Nurtec migraine ad for Pfizer

Lady Gaga returns in a new Nurtec migraine ad for Pfizer
Beth Snyder Bulik ENDPTS
09 Apr 2024
Share Share
Pfizer`s Vydura gets NICE nod to treat episodic migraine attacks

Pfizer`s Vydura gets NICE nod to treat episodic migraine attacks
Kevin Dunleavy FIERCE PHARMA
13 Sep 2023
Share Share
Eli Lilly`s migraine drug fails to prove superiority to Pfizer`s

Eli Lilly`s migraine drug fails to prove superiority to Pfizer`s
REUTERS
17 Jun 2023
Share Share
NICE recommends Pfizer`s migraine drug for use in the UK, with some restrictions

NICE recommends Pfizer`s migraine drug for use in the UK, with some restrictions
Paul Schloesser ENDPTS
01 Jun 2023
Share Share
First-in-class migraine treatment Vydura approved for NHS Scotland

First-in-class migraine treatment Vydura approved for NHS Scotland
Akosua Mireku PHARMACEUTICAL TECHNOLOGY
10 May 2023
Share Share
Judge mulls banning abortion pill in US, questions regulatory approval

Judge mulls banning abortion pill in US, questions regulatory approval
REUTERS
16 Mar 2023
Share Share
Pfizer Completes Acquisition of Biohaven Pharmaceuticals

Pfizer Completes Acquisition of Biohaven Pharmaceuticals
PRESS RELEASE
04 Oct 2022
Share Share
Biohaven announced the important findings pertaining to the benefit of Nurtec

Biohaven announced the important findings pertaining to the benefit of Nurtec
PRNEWSWIRE
31 Aug 2022
Share Share
Biohaven touts surge in Nurtec sales ahead of Pfizer takeover

Biohaven touts surge in Nurtec sales ahead of Pfizer takeover
Nicole DeFeudis ENDPTS
06 Aug 2022
Share Share